<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="36c4da56-502e-4da1-acf7-8e81ee453dcc"><labelDrug name="Minipress"><Normalization><mmtx cui="C0242447" preferredWord="Minipress" semType="phsu, orch"/></Normalization></labelDrug><generic name="PRAZOSIN HYDROCHLORIDE"/><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.1" text="MINIPRESS (prazosin hydrochloride) capsule" type="negative"><entity charOffset="0:9" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.1.e.0" text="minipress" type="Biomedical_Entity"><Normalization><mmtx cui="C0242447" phraseText="MINIPRESS" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><entity charOffset="11:33" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.1.e.1" text="prazosin hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700578" phraseText="(prazosin hydrochloride" preferredWord="Prazosin hydrochloride" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.1.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.1.e.1"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.2" text="MINIPRESS (prazosin hydrochloride), a quinazoline derivative, is the first of a new chemical class of antihypertensives." type="negative"><entity charOffset="102:119" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.2.e.0" text="antihypertensives" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the first of a new chemical class of antihypertensives." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="11:33" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.2.e.1" text="prazosin hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700578" phraseText="(prazosin hydrochloride" preferredWord="Prazosin hydrochloride" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.2.e.2" text="minipress" type="Biomedical_Entity"><Normalization><mmtx cui="C0242447" phraseText="MINIPRESS" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.2.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.2.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.2.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.2.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.2.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.2.e.1"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.4" text="MINIPRESS is contraindicated in patients with known sensitivity to quinazolines, prazosin, or any of the inert ingredients." type="negative"><entity charOffset="105:122" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.4.e.0" text="inert ingredients" type="Biomedical_Entity"><Normalization><mmtx cui="C1968272" phraseText="any of the inert ingredients." preferredWord="Inert Ingredients" semType="phsu"/><RxNorm RxCui="4691"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.4.e.1" text="minipress" type="Biomedical_Entity"><Normalization><mmtx cui="C0242447" phraseText="MINIPRESS" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><entity charOffset="81:89" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.4.e.2" text="prazosin" type="Biomedical_Entity"><Normalization><mmtx cui="C0032912" phraseText="prazosin," preferredWord="Prazosin" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.4.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.4.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.4.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.4.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.4.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.4.e.2"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.6" text="As with all alpha-blockers, MINIPRESS may cause syncope with sudden loss of consciousness. " type="negative"><entity charOffset="12:26" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.6.e.0" text="alpha-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="As with all alpha-blockers," preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="1023426"/></Normalization></entity><entity charOffset="28:37" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.6.e.1" text="minipress" type="Biomedical_Entity"><Normalization><mmtx cui="C0242447" phraseText="MINIPRESS" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.6.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.6.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9" lineNumber="11" text="occasionally, they have been reported in association with rapid dosage increases or the introduction of another antihypertensive drug into the regimen of a patient taking high doses of MINIPRESS. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.8" Text="Syncopal episodes have usually occurred within 30 to 90 minutes of the initial dose of the drug; "/><anaphoraEntity charOffset="14:18" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9.e.4" text="they" type="Expression"/><antecedentEntity charOffset="0:17" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.8.e.0" text="Syncopal episodes" type="SPAN"/></anaphoraRelation><entity charOffset="112:133" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9.e.0" text="antihypertensive drug" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="the introduction of another antihypertensive drug" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="185:194" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9.e.1" text="MINIPRESS" type="Drug"><Normalization><mmtx cui="C0242447" phraseText="high doses of MINIPRESS." preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><entity charOffset="14:18" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9.e.2" text="they" type="Specific_Interaction"/><drugInteraction id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9.ddi.1"><interaction trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9.e.2"><relations><relation type="hasObject"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9.e.1" trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.9.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.11" text="Clinical trials conducted during the investigational phase of this drug suggest that syncopal episodes can be minimized by limiting the initial dose of the drug to 1 mg, by subsequently increasing the dosage slowly, and by introducing any additional antihypertensive drugs into the patient's regimen with caution (see DOSAGE AND ADMINISTRATION). " type="negative"><entity charOffset="37:71" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.11.e.0" text="investigational drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013230" phraseText="conducted during the investigational phase of this drug" preferredWord="Investigational New Drugs" semType="phsu"/><RxNorm RxCui="691721"/></Normalization></entity><entity charOffset="250:272" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.11.e.1" text="antihypertensive drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="any additional antihypertensive drugs into the patient's regimen" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.11.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.11.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12" lineNumber="11" text="Hypotension may develop in patients given MINIPRESS who are also receiving a beta-blocker such as propranolol." type="regular"><entity charOffset="0:11" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.0" text="Hypotension" type="Specific_Interaction"/><entity charOffset="42:51" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.2" text="MINIPRESS" type="Drug"><Normalization><mmtx cui="C0242447" phraseText="MINIPRESS" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><entity charOffset="77:89" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.3" text="beta-blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="a beta-blocker such as propranolol." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="98:109" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.4" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="a beta-blocker such as propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><drugClassMembership drug="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.4" drugClass="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.3"/><drugInteraction id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.ddi.1"><interaction trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.3" trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.12.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.25" text="There does not appear to be a benefit of stopping alpha-1 blocker therapy prior to cataract surgery." type="negative"><entity charOffset="41:49" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.25.e.0" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="a benefit of stopping alpha-1 blocker therapy" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><entity charOffset="50:65" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.25.e.1" text="alpha blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="a benefit of stopping alpha-1 blocker therapy" preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.25.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.25.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.31" lineNumber="27" text="These effects may also occur if you drink alcohol, stand for long periods of time, exercise, or if the weather is hot. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.29" Text="Dizziness, lightheadedness, or fainting may occur, especially when rising from a lying or sitting position. "/><anaphoraEntity charOffset="0:13" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.31.e.1" text="These effects" type="Expression"/><antecedentEntity charOffset="0:39" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.29.e.0" text="Dizziness, lightheadedness, or fainting" type="SPAN"/></anaphoraRelation><entity charOffset="42:49" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.31.e.0" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="alcohol," preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="0:13" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.31.e.2" text="These effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.31.ddi.1"><interaction trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.31.e.2"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.19" text="The patient should also be cautioned to avoid situations where injury could result should syncope occur during the initiation of MINIPRESS therapy."><entity charOffset="129:138" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.19.e.0" text="MINIPRESS" type="Drug"><Normalization><mmtx cui="C0242447" phraseText="occur during the initiation of MINIPRESS therapy." preferredWord="Minipress" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.20" text="PRECAUTIONS"/><middleSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.21" text="General"/><middleSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.22" text="Intraoperative Floppy Iris Syndrome (IFIS) has been observed during cataract surgery in some patients treated with alpha-1 blockers. "/><middleSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.23" text="This variant of small pupil syndrome is characterized by the combination of a flaccid iris that billows in response to intraoperative irrigation currents, progressive intraoperative miosis despite preoperative dilation with standard mydriatic drugs, and potential prolapse of the iris toward the phacoemulsification incisions. "/><middleSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.24" text="The patient's ophthalmologist should be prepared for possible modifications to the surgical technique, such as the utilization of iris hooks, iris dilator rings, or viscoelastic substances. "/><middleSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.25" text="There does not appear to be a benefit of stopping alpha-1 blocker therapy prior to cataract surgery."/><middleSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.26" text="Information for Patients"/><middleSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.27" text="Dizziness or drowsiness may occur after the first dose of this medicine. "/><middleSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.28" text="Avoid driving or performing hazardous tasks for the first 24 hours after taking this medicine or when the dose is increased. "/><middleSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.29" text="Dizziness, lightheadedness, or fainting may occur, especially when rising from a lying or sitting position. "/><middleSentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.30" text="Getting up slowly may help lessen the problem. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.31.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.31.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.32" lineNumber="27" text="While taking MINIPRESS, be careful in the amount of alcohol you drink. " type="regular"><entity charOffset="52:59" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.32.e.0" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="careful in the amount of alcohol" preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="13:22" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.32.e.1" text="MINIPRESS" type="Drug"><Normalization><mmtx cui="C0242447" phraseText="taking MINIPRESS," preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><entity charOffset="27:48|60:69" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.32.e.2" text="careful in the amount you drink" type="Caution_Interaction"/><drugInteraction id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.32.ddi.1"><interaction trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.32.e.2"><relations><relation type="hasObject"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.32.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.32.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.32.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.32.e.0" trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.32.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36" text="MINIPRESS has been administered without any adverse drug interaction in limited clinical experience to date with the following: (1) cardiac glycosides digitalis and digoxin; " type="negative"><entity charOffset="132:150" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.0" text="cardiac glycosides" type="Biomedical_Entity"><Normalization><mmtx cui="C0007158" phraseText="cardiac glycosides digitalis" preferredWord="Cardiac Glycosides" semType="phsu, carb"/><RxNorm RxCui="1025351"/></Normalization></entity><entity charOffset="165:172" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.2" text="minipress" type="Biomedical_Entity"><Normalization><mmtx cui="C0242447" phraseText="MINIPRESS" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><entity charOffset="151:160" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.3" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="cardiac glycosides digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.3"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.36.e.3"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37" text="(2) hypoglycemics insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; " type="negative"><entity charOffset="55:65" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.0" text="tolazamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0040372" phraseText="tolazamide," preferredWord="Tolazamide" semType="phsu, orch"/><RxNorm RxCui="10633"/></Normalization></entity><entity charOffset="27:41" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.1" text="chlorpropamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0008287" phraseText="chlorpropamide," preferredWord="Chlorpropamide" semType="phsu, orch"/><RxNorm RxCui="2404"/></Normalization></entity><entity charOffset="18:25" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.2" text="insulin" type="Biomedical_Entity"><Normalization><mmtx cui="C0021641" phraseText="hypoglycemics insulin," preferredWord="Insulin" semType="phsu, aapp, horm"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="71:82" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.3" text="tolbutamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0040374" phraseText="tolbutamide" preferredWord="Tolbutamide" semType="phsu, orch"/><RxNorm RxCui="10635"/></Normalization></entity><entity charOffset="4:17" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.4" text="hypoglycemics" type="Biomedical_Entity"><Normalization><mmtx cui="C0020616" phraseText="hypoglycemics insulin," preferredWord="Hypoglycemic Agents" semType="phsu"/><RxNorm RxCui="5604"/></Normalization></entity><entity charOffset="43:53" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.5" text="phenformin" type="Biomedical_Entity"><Normalization><mmtx cui="C0031404" phraseText="phenformin," preferredWord="Phenformin" semType="phsu, orch, hops"/><RxNorm RxCui="8129"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.3"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.5" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.3"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.5"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.3"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.2"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.5"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.3"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.5" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.3"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.37.e.5"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38" text="(3) tranquilizers and sedatives chlordiazepoxide, diazepam, and phenobarbital; " type="negative"><entity charOffset="64:77" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.0" text="phenobarbital" type="Biomedical_Entity"><Normalization><mmtx cui="C0031412" phraseText="phenobarbital" preferredWord="Phenobarbital" semType="phsu, orch"/><RxNorm RxCui="8134"/></Normalization></entity><entity charOffset="50:58" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.1" text="diazepam" type="Biomedical_Entity"><Normalization><mmtx cui="C0012010" phraseText="diazepam," preferredWord="Diazepam" semType="phsu, orch"/><RxNorm RxCui="3322"/></Normalization></entity><entity charOffset="32:48" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.2" text="chlordiazepoxide" type="Biomedical_Entity"><Normalization><mmtx cui="C0008188" phraseText="sedatives chlordiazepoxide," preferredWord="Chlordiazepoxide" semType="phsu, orch"/><RxNorm RxCui="203173"/></Normalization></entity><entity charOffset="4:17" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.3" text="tranquilizers" type="Biomedical_Entity"><Normalization><mmtx cui="C0040614" phraseText="tranquilizers" preferredWord="Tranquilizing Agents" semType="phsu"/><RxNorm RxCui="10692"/></Normalization></entity><entity charOffset="22:31" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.4" text="sedatives" type="Biomedical_Entity"><Normalization><mmtx cui="C0036557" phraseText="sedatives chlordiazepoxide," preferredWord="Sedatives" semType="phsu"/><RxNorm RxCui="9634"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.2"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.2"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.38.e.4"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.39" text="(4) antigout allopurinol, colchicine, and probenecid; " type="negative"><entity charOffset="13:24" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.39.e.0" text="allopurinol" type="Biomedical_Entity"><Normalization><mmtx cui="C0002144" phraseText="antigout allopurinol," preferredWord="Allopurinol" semType="phsu, orch"/><RxNorm RxCui="519"/></Normalization></entity><entity charOffset="26:36" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.39.e.1" text="colchicine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009262" phraseText="colchicine," preferredWord="Colchicine" semType="phsu, orch"/><RxNorm RxCui="2683"/></Normalization></entity><entity charOffset="42:52" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.39.e.2" text="probenecid" type="Biomedical_Entity"><Normalization><mmtx cui="C0033209" phraseText="probenecid" preferredWord="Probenecid" semType="phsu, orch"/><RxNorm RxCui="8698"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.39.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.39.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.39.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.39.e.2"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.39.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.39.e.2"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40" text="(5) antiarrhythmics procainamide, propranolol (see WARNINGS however), and quinidine; " type="negative"><entity charOffset="4:19" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.0" text="antiarrhythmics" type="Biomedical_Entity"><Normalization><mmtx cui="C0003195" phraseText="antiarrhythmics procainamide," preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="883"/></Normalization></entity><entity charOffset="34:45" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.1" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="74:83" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.2" text="quinidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0034414" phraseText="quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="20:32" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.3" text="procainamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0033216" phraseText="antiarrhythmics procainamide," preferredWord="Procainamide" semType="phsu, orch"/><RxNorm RxCui="155056"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.2"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.3"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.2"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.40.e.2"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41" text="and (6) analgesics, antipyretics and anti-inflammatories propoxyphene, aspirin, indomethacin, and phenylbutazone." type="negative"><entity charOffset="80:92" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.0" text="indomethacin" type="Biomedical_Entity"><Normalization><mmtx cui="C0021246" phraseText="indomethacin," preferredWord="Indomethacin" semType="phsu, orch"/><RxNorm RxCui="5781"/></Normalization></entity><entity charOffset="71:78" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.1" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="aspirin," preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="57:69" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.2" text="propoxyphene" type="Biomedical_Entity"><Normalization><mmtx cui="C0033493" phraseText="anti-inflammatories propoxyphene," preferredWord="Propoxyphene" semType="phsu, orch"/><RxNorm RxCui="8785"/></Normalization></entity><entity charOffset="20:32" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.3" text="antipyretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0003419" phraseText="antipyretics" preferredWord="Antipyretics" semType="phsu"/><RxNorm RxCui="1000"/></Normalization></entity><entity charOffset="37:56" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.4" text="anti-inflammatories" type="Biomedical_Entity"><Normalization><mmtx cui="C0003209" phraseText="anti-inflammatories propoxyphene," preferredWord="Anti-Inflammatory Agents" semType="phsu"/><RxNorm RxCui="691961"/></Normalization></entity><entity charOffset="98:112" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.5" text="phenylbutazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0031463" phraseText="phenylbutazone." preferredWord="Phenylbutazone" semType="phsu, orch"/><RxNorm RxCui="8160"/></Normalization></entity><entity charOffset="8:18" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.6" text="analgesics" type="Biomedical_Entity"><Normalization><mmtx cui="C0002771" phraseText="analgesics," preferredWord="Analgesics" semType="phsu"/><RxNorm RxCui="760"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.5"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.6" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.5"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.6" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.1"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.2"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.2"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.5"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.6" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.2"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.4"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.5"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.6" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.3"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.4" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.5"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.6" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.4"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.6" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.41.e.5"/></sentence><sentence biomedicalEntities="3" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42" lineNumber="33" text="Addition of a diuretic or other antihypertensive agent to MINIPRESS has been shown to cause an additive hypotensive effect. " type="regular"><entity charOffset="58:67" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.0" text="MINIPRESS" type="Drug"><Normalization><mmtx cui="C0242447" phraseText="other antihypertensive agent to MINIPRESS" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><entity charOffset="14:22" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.1" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Addition of a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="32:54" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.2" text="antihypertensive agent" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="other antihypertensive agent to MINIPRESS" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="95:122" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.3" text="additive hypotensive effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.ddi.1"><interaction trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.0" trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.0" trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.3" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.42.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.43" lineNumber="33" text="This effect can be minimized by reducing the MINIPRESS dose to 1 to 2 mg three times a day, by introducing additional antihypertensive drugs cautiously, and then by retitrating MINIPRESS based on clinical response." type="regular"><entity charOffset="118:140" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.43.e.0" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="by introducing additional antihypertensive drugs cautiously," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="95:106|141:151" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.43.e.1" text="introducing cautiously" type="Caution_Interaction"/><entity charOffset="45:54" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.43.e.3" text="MINIPRESS" type="Drug"><Normalization><mmtx cui="C0242447" phraseText="the MINIPRESS dose to 1" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><drugInteraction id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.43.ddi.1"><interaction trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.43.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.43.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.43.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.43.e.3" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.43.e.0" trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.43.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44" lineNumber="35" text="Concomitant administration of MINIPRESS with a phosphodiesterase-5 (PDE-5) inhibitor can result in additive blood pressure lowering effects and symptomatic hypotension (see DOSAGE AND ADMINISTRATION)." type="regular"><entity charOffset="30:39" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.0" text="MINIPRESS" type="Drug"><Normalization><mmtx cui="C0242447" phraseText="Concomitant administration of MINIPRESS" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><entity charOffset="47:84" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.1" text="phosphodiesterase-5 (PDE-5) inhibitor" type="Drug_Class"><Normalization><mmtx cui="C1318700" phraseText="with a phosphodiesterase-5 (PDE-5) inhibitor" preferredWord="Phosphodiesterase 5 inhibitor" semType="phsu"/><mmtx cui="C2923059" phraseText="with a phosphodiesterase-5 (PDE-5) inhibitor" preferredWord="Phosphodiesterase 5 Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="230032"/></Normalization></entity><entity charOffset="99:139" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.2" text="additive blood pressure lowering effects" type="Specific_Interaction"/><entity charOffset="144:167" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.4" text="symptomatic hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.ddi.1"><interaction trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.ddi.2"><interaction trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.1" trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.44.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.46" text="In a study on five patients given from 12 to 24 mg of prazosin per day for 10 to 14 days, there was an average increase of 42% in the urinary metabolite of norepinephrine and an average increase in urinary VMA of 17%. " type="negative"><entity charOffset="54:62" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.46.e.0" text="prazosin" type="Biomedical_Entity"><Normalization><mmtx cui="C0032912" phraseText="of prazosin" preferredWord="Prazosin" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><entity charOffset="156:170" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.46.e.1" text="norepinephrine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028351" phraseText="of norepinephrine" preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.46.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.46.e.1"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.57" text="In view of the testicular changes observed in animals, 105 patients on long term MINIPRESS therapy were monitored for 17-ketosteroid excretion and no changes indicating a drug effect were observed. " type="negative"><entity charOffset="81:90" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.57.e.0" text="minipress" type="Biomedical_Entity"><Normalization><mmtx cui="C0242447" phraseText="105 patients on long term MINIPRESS therapy" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><entity charOffset="118:132" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.57.e.1" text="17-ketosteroid" type="Biomedical_Entity"><Normalization><mmtx cui="C0000167" phraseText="monitored for 17-ketosteroid excretion" preferredWord="17-Ketosteroids" semType="strd, phsu, horm"/><RxNorm RxCui="21"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.57.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.57.e.1"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.64" text="The use of prazosin and a beta-blocker for the control of severe hypertension in 44 pregnant women revealed no drug-related fetal abnormalities or adverse effects. " type="negative"><entity charOffset="26:38" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.64.e.0" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="a beta-blocker for the control of severe hypertension" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="11:19" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.64.e.1" text="prazosin" type="Biomedical_Entity"><Normalization><mmtx cui="C0032912" phraseText="The use of prazosin" preferredWord="Prazosin" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.64.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.64.e.0"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.66" text="Prazosin has also been used alone or in combination with other hypotensive agents in severe hypertension of pregnancy by other investigators. " type="negative"><entity charOffset="0:8" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.66.e.0" text="prazosin" type="Biomedical_Entity"><Normalization><mmtx cui="C0032912" phraseText="Prazosin" preferredWord="Prazosin" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><entity charOffset="63:81" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.66.e.1" text="hypotensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="with other hypotensive agents" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.66.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.66.e.1"/></sentence><sentence id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.86" text="When adding a diuretic or other antihypertensive agent, the dose of MINIPRESS should be reduced to 1 mg or 2 mg three times a day and retitration then carried out." type="negative"><entity charOffset="32:54" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.86.e.0" text="antihypertensive agent" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="other antihypertensive agent," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="14:22" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.86.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="68:77" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.86.e.2" text="minipress" type="Biomedical_Entity"><Normalization><mmtx cui="C0242447" phraseText="the dose of MINIPRESS" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.86.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.86.e.0"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.86.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.86.e.2"/><pair ddi="false" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.86.e.1" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.86.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87" lineNumber="85" text="Concomitant administration of MINIPRESS with a PDE-5 inhibitor can result in additive blood pressure lowering effects and symptomatic hypotension; " type="regular"><entity charOffset="30:39" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.0" text="MINIPRESS" type="Drug"><Normalization><mmtx cui="C0242447" phraseText="Concomitant administration of MINIPRESS" preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><entity charOffset="47:62" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.1" text="PDE-5 inhibitor" type="Drug_Class"><Normalization><mmtx cui="C1318700" phraseText="with a PDE-5 inhibitor" preferredWord="Phosphodiesterase 5 inhibitor" semType="phsu"/><mmtx cui="C2923059" phraseText="with a PDE-5 inhibitor" preferredWord="Phosphodiesterase 5 Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="1022271"/></Normalization></entity><entity charOffset="77:117" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.2" text="additive blood pressure lowering effects" type="Specific_Interaction"/><entity charOffset="122:145" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.4" text="symptomatic hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.ddi.1"><interaction trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.2"><relations><relation type="hasObject"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.ddi.2"><interaction trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.4"><relations><relation type="hasObject"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.0" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.1" trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.87.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.88" lineNumber="85" text="therefore, PDE-5 inhibitor therapy should be initiated at the lowest dose in patients taking MINIPRESS." type="regular"><entity charOffset="45:73" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.88.e.0" text="initiated at the lowest dose" type="Caution_Interaction"/><entity charOffset="11:34" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.88.e.2" text="PDE-5 inhibitor therapy" type="Drug_Class"><Normalization><mmtx cui="C1318700" phraseText="PDE-5 inhibitor therapy" preferredWord="Phosphodiesterase 5 inhibitor" semType="phsu"/><mmtx cui="C2923059" phraseText="PDE-5 inhibitor therapy" preferredWord="Phosphodiesterase 5 Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="1022271"/></Normalization></entity><entity charOffset="93:102" id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.88.e.3" text="MINIPRESS" type="Drug"><Normalization><mmtx cui="C0242447" phraseText="MINIPRESS." preferredWord="Minipress" semType="phsu, orch"/><RxNorm RxCui="71515"/></Normalization></entity><drugInteraction id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.88.ddi.1"><interaction trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.88.e.0"><relations><relation type="hasObject"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.88.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.88.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.88.e.2" e2="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.88.e.3" trigger="Dailymed.36c4da56-502e-4da1-acf7-8e81ee453dcc.s.88.e.0" type="Caution_Interaction"/></sentence><positiveExamples number="10"/><negativeExamples number="79"/></document>